Exercise Training and Vitamin D Metabolism
Hybri-D
The Impact of Hybrid-type High-intensity Interval Training on Vitamin D Metabolism in Adults With Overweight/Obesity
1 other identifier
interventional
30
1 country
1
Brief Summary
The prevalence of Vitamin D deficiency is significantly higher in adults with overweight/obesity compared to those with normal body mass index (BMI). The "entrapment" of Vitamin D in adipose tissue due to impaired lipolytic stimulation and/or adipose tissue dysfunction has been proposed as the driving mechanism. Exercise training has been proposed as a promising strategy to increase mobilization of Vitamin D from adipose tissue, given its well described role in stimulating lipolysis. Indeed, a recent study revealed that participation in moderate-intensity cardiovascular type exercise over winter can mitigate the decline in 25-hydroxyvitamin D \[25(OH)D\] in adults with overweight/obesity, independent of weight loss. The aim of this study is to investigate the impact of hybrid-type high-intensity interval training over winter on vitamin D metabolism, in adults with overweight/obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 10, 2025
CompletedFirst Submitted
Initial submission to the registry
December 9, 2025
CompletedFirst Posted
Study publicly available on registry
December 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 20, 2026
ExpectedMay 26, 2026
May 1, 2026
3 months
December 9, 2025
May 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Change in 25-hydroxyvitamin D concentration
25-OH-VD will be quantitatively determined in serum
At baseline, 6 weeks and 12 weeks
Change in plasma Vitamin D binding protein concentration
Vitamin D binding protein concentration will be determined in plasma
At baseline, 6 weeks and 12 weeks
Change in calcium concentration
Calcium concentration will be determined in serum
At baseline, 6 weeks and 12 weeks
Change in albumin concentration
Albumin concentration will be determined in serum
At baseline, 6 weeks and 12 weeks
Change in aspartate aminotransferase (SGOT) concentration
SGOT concentration will be determined in serum on a Clinical Chemistry analyzer
At baseline, 6 weeks and 12 weeks
Change in alanine aminotransferase (SGPT) concentration
SGPT concentration will be determined in serum on a Clinical Chemistry analyzer
At baseline, 6 weeks and 12 weeks
Change in gamma-glutamyl transferase (γ-GT) concentration
γ-GT concentration will be determined in serum on a Clinical Chemistry analyzer
At baseline, 6 weeks and 12 weeks
Secondary Outcomes (5)
Change in reduced glutathione concentration
At baseline, 6 weeks and 12 weeks
Change in oxidized glutathione concentration
At baseline, 6 weeks and 12 weeks
Change in dietary intake
At baseline, 6 weeks and 12 weeks
Change in physical activity level
At baseline, 6 weeks and 12 weeks
Change in body composition
At baseline, 6 weeks and 12 weeks
Study Arms (2)
Exercise group
EXPERIMENTALExercise group will participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period, while receiving a balanced diet
Control group
ACTIVE COMPARATORControl group will receive a balanced diet but will not participate in exercise training
Interventions
Receive a balanced diet and participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period
Eligibility Criteria
You may qualify if:
- BMI = 25-35 kg/m2
- Absence of musculoskeletal injuries
- Absence of chronic health-related complications
- Non-smokers
You may not qualify if:
- Consumption of Vitamin D supplements
- Consumption of anti-inflammatory drugs, statins and/or steroids
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Physical Education and Sport Science, University of Thessaly
Trikala, Karyes, 42100, Greece
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dimitrios Draganidis, PhD
University of Thessaly
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 9, 2025
First Posted
December 23, 2025
Study Start
November 10, 2025
Primary Completion
January 31, 2026
Study Completion (Estimated)
July 20, 2026
Last Updated
May 26, 2026
Record last verified: 2026-05